HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SIGA
SIGA Technologies, Inc.
SIGA's fundamentals are weak and it looks expensive: trading at 289x earnings, about 30 times its usual 9.6x. Its downside scenario is more than ten times its upside.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SIGA Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Strong |
SIGA's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SIGA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.4x | $0.06 | -98% |
| Fair | 9.5x | $0.10 | -97% |
| Expensive | 16x | $0.16 | -94% |
| Current | 289x | $2.89 | โ |
Historical ranges are pointers, not guarantees.
SIGA's PE is in its expensive range at 289x.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SIGA Forward outlook
There aren't enough analyst estimates for SIGA to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
SIGA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.01 | -99% |
| Q2 2026 | -$0.04 | -104% |
| Q1 2026 | $0.28 | -58% |
| Q4 2025 | $0.32 | -61% |
| Q3 2025 | $1.02 | -15% |
| Q2 2025 | $1.13 | -3.4% |
| Q1 2025 | $0.67 | -39% |
| Q4 2024 | $0.82 | -14% |
SIGA has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SIGA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over SIGA on profitability, with a higher operating margin.
SIGA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3M | -50% |
| Q2 2026 | $41M | -49% |
| Q1 2026 | $6.2M | -11% |
| Q4 2025 | $3.8M | -95% |
| Q3 2025 | $2.6M | -74% |
| Q2 2025 | $81.1M | +272% |
| Q1 2025 | $7M | -72% |
| Q4 2024 | $81.5M | -30% |
SIGA's revenue has slid since its 2023 peak: $1M last quarter, down 50% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -495% | -105 points |
| Q2 2026 | 34% | -22 points |
| Q1 2026 | -85% | -53 points |
| Q4 2025 | -250% | -320 points |
| Q3 2025 | -390% | -396 points |
| Q2 2025 | 56% | +51 points |
| Q1 2025 | -32% | -76 points |
| Q4 2024 | 70% | -8.6 points |
SIGA's operating margin was โ495% last quarter, down 105 points from the same quarter a year ago, near the bottom of its range since 2019.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SIGA on cash generation, producing positive trailing cash flow while its opponent burns cash.
SIGA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2M | +$8.9M |
| Q2 2026 | $15.2M | -76% |
| Q1 2026 | -$8.7M | -223% |
| Q4 2025 | -$16.9M | -130% |
| Q3 2025 | -$10.1M | -$2.7M |
| Q2 2025 | $63.1M | +960% |
| Q1 2025 | $7M | +$13.2M |
| Q4 2024 | $56.3M | -29% |
SIGA's free cash flow was โ$12M over the past year, against $116M the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SIGA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -6.9x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -2.9x | Net Cash |
| Q4 2024 | -2.2x | Net Cash |
| Q3 2024 | -0.9x | Net Cash |
| Q2 2024 | -1.0x | Net Cash |
SIGA has the edge over HIMS on leverage, with a lower net debt burden relative to earnings.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SIGA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 21.2 | Neutral |
SIGA's weekly RSI is 33 (neutral) and its Stochastic is 21 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
HIMS has no meaningful PE right now: it lost money over the past year.
SIGA PE vs Healthcare Sector
| Metric | SIGA | Sector median | Relative |
|---|---|---|---|
| PE | 289x | 26x | 1,018% above |
| PE % | 100 | 29 | 71 pts above |
SIGA is trading at 289x earnings, a 1018% premium to the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SIGA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.18 | 9.1% below |
| 20 week MA | $3.22 | 10% below |
| 50 week MA | $4.58 | 37% below |
| 100 week MA | $5.66 | 49% below |
| 200 week MA | $6.08 | 52% below |
SIGA is in a downtrend: it's below all five of its weekly moving averages, and 52% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over SIGA on returns for 2026, with the stronger performance.
SIGA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.79 | $7.34 | +53% |
| 2021 | $7.34 | $7.99 | +8.9% |
| 2022 | $7.99 | $7.76 | -2.9% |
| 2023 | $7.76 | $5.60 | -28% |
| 2024 | $5.60 | $5.93 | +5.9% |
| 2025 | $5.93 | $6.27 | +5.7% |
| 2026 YTD | $6.27 | $2.89 | -54% |
SIGA is down 54% so far in 2026, after finishing higher in four of the previous six years.